🔗 Permalink

Inventor profile of:

Daniel R. Deaver

City:

Franklin, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-10-09

Top Assignees for applications by Daniel R. Deaver

The entities that hold a legal rights for patent applications filed by inventor Deaver Daniel R.:

ALKERMES PHARMA IRELAND LIMITED 19 Dublin, Ireland
The Penn State Research Foundation 1 University Park, PA United States
Advanced Inhalation Research, Inc. 1 Cambridge, MA United States
Alkermes, Inc. 1 Waltham, MA United States
ALKERMES PHARMA IRELAND LIMITED 1 Waltham, MA United States

Recent patent applications by Deaver Daniel R.

Daniel R. Deaver from Franklin, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-09

US20250312459A1

Human necessities

Pharmaceutical Compositions Having Improved Storage Stability

#2 | 2024-09-19

US20240307542A1

Human necessities

Pharmaceutical compositions having improved storage stability

#3 | 2024-04-25

US20240131024A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS

#4 | 2024-02-22

US20240058327A1

Human necessities

Pharmaceutical Compositions Comprising Sorbitan Esters

#5 | 2023-05-25

US20230158017A1

Human necessities

Methods for treating depressive symptoms

#6 | 2022-03-10

US20220072133A1

Human necessities

Pharmaceutical compositions having improved storage stability

#7 | 2021-01-07

US20210000818A1

Human necessities

Methods for treating depressive symptoms

#8 | 2020-08-27

US20200268891A1

Human necessities

Pharmaceutical compositions having improved storage stability

#9 | 2019-09-12

US20190275155A1

Human necessities

Pharmaceutical compositions having improved storage stability

#10 | 2019-07-18

US20190218185A1

Chemistry; metallurgy

Morphan and morphinan analogues, and methods of use

#11 | 2019-07-18

US20190216805A1

Human necessities

Pharmaceutical Compositions Comprising Sorbitan Esters

#12 | 2019-06-06

US20190167666A1

Human necessities

Methods for treating depressive symptoms

#13 | 2018-01-18

US20180016237A1

Chemistry; metallurgy

Morphan and morphinan analogues, and methods of use

#14 | 2018-01-04

US20180000944A1

Human necessities

Pharmaceutical compositions having improved storage stability

#15 | 2017-08-03

US20170216279A1

Human necessities

Methods for treating depressive symptoms

#16 | 2017-07-13

US20170196856A1

Human necessities

Pharmaceutical compositions comprising sorbitan esters

#17 | 2016-11-10

US20160326119A1

Chemistry; metallurgy

Morphan and morphinan analogues, and methods of use

#18 | 2016-05-19

US20160136279A1

Human necessities

Pharmaceutical compositions having improved storage stability

#19 | 2016-02-11

US20160038508A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS

#20 | 2015-12-31

US20150376197A1

Chemistry; metallurgy

Morphan and morphinan analogues, and methods of use

#21 | 2015-09-17

US20150258115A1

Human necessities

Pharmaceutical compositions comprising sorbitan esters

#22 | 2015-03-12

US20150072971A1

Chemistry; metallurgy

Methods for treating depressive symptoms

#23 | 2014-03-27

US20140088115A1

Chemistry; metallurgy

Pharmaceutical compositions having improved storage stability

#24 | 2012-09-20

US20120238552A1

Human necessities

Pharmaceutical compositions comprising sorbitan esters

#25 | 2005-11-17

US20050255152A1

Human necessities

System for enhanced targeted delivery

#26 | 2005-10-20

US20050232872A1

Human necessities

Compositions and methods for enhancing receptor-mediated cellular internalization

#27 | 2005-06-21

US10717251

Compositions and methods for enhancing receptor-mediated cellular internalization

#28 | 2005-01-06

US20050003003A1

Human necessities

Modulation of release from dry powder formulations

InventorID:

705025 ⎘